Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.76
Price to sales ratio
2.35

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2435
PCRX
Pacira BioSciences, Inc. - Common Stock
25.65 USD-0.70%+7.91%-4.29%+17.50%1.02 B USD
2503
AMPH
Amphastar Pharmaceuticals, Inc. - Common Stock
21.85 USD-0.14%-0.41%+7.95%-10.38%929.45 M USD
2708
EVO
Evotec SE - American Depositary Shares each representing 1/2 of
1.91 USD-3.05%-2.05%-3.05%-55.27%679.12 M USD
2718
IRWD
Ironwood Pharmaceuticals, Inc. - Class A Common Stock
4.12 USD-2.83%-2.60%+8.42%+212.12%680.79 M USD

Frequently asked questions about Collegium Pharmaceutical, Inc. Common Stock

What is the Collegium Pharmaceutical, Inc. Common Stock stock price today?

The current price of Collegium Pharmaceutical, Inc. Common Stock (COLL) is 26.44. Over the past 24 hours, the stock has changed by +0.15%. Follow the COLL chart for real-time price dynamics.

What is the stock ticker of Collegium Pharmaceutical, Inc. Common Stock?

Collegium Pharmaceutical, Inc. Common Stock trades under the ticker COLL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Collegium Pharmaceutical, Inc. Common Stock stock going up?

COLL has changed by -2.97% over the last week, -26.47% over the last month, and -24.76% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Collegium Pharmaceutical, Inc. Common Stock?

Collegium Pharmaceutical, Inc. Common Stock currently has a market capitalization of 860.77 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Collegium Pharmaceutical, Inc. Common Stock earnings last quarter?

Last quarter, Collegium Pharmaceutical, Inc. Common Stock reported earnings of -0.46 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Collegium Pharmaceutical, Inc. Common Stock revenue for the last quarter?

Collegium Pharmaceutical, Inc. Common Stock reported quarterly revenue of 199.88 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Collegium Pharmaceutical, Inc. Common Stock net income for the last quarter?

Collegium Pharmaceutical, Inc. Common Stock reported net income of -15.05 M for the last quarter. The previous quarter showed 14.5 M, which means net income changed by -203.83%.

How many employees does Collegium Pharmaceutical, Inc. Common Stock have?

As of the latest available data, Collegium Pharmaceutical, Inc. Common Stock has 423 employees. Workforce size can provide additional context about the company's scale and operations.

What is Collegium Pharmaceutical, Inc. Common Stock EBITDA?

Collegium Pharmaceutical, Inc. Common Stock EBITDA is 132.45 M, and its EBITDA margin is 66.27%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Collegium Pharmaceutical, Inc. Common Stock stock?

You can buy Collegium Pharmaceutical, Inc. Common Stock (COLL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Collegium Pharmaceutical, Inc. Common Stock stock?

Investing in Collegium Pharmaceutical, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COLL chart and related analysis on metatrader.com as part of your research.

News